Browse by topic
Subscribe to our blog

Overcoming medication adherence barriers in oral anticancer meds

Over the past decade, treatment in a variety of cancers, particularly breast cancer, chronic myelogenous leukemia, and non-small cell lung cancer, has switched from intermittent intravenous therapy to self-administered targeted oral anticancer ...
Read

Special report: behavioral marketing trends for pharma brands

Produced by MM+M and sponsored by AllazoHealth, this free special report offers a deep dive into how recent innovations in behavioral marketing and economics empower pharma marketers. You’ll learn about how behavioral insights shape strategy and ...
Read

Case study: Leading pharma brand achieves 4.6x increased days on therapy

Overcoming an adherence challenge This case study shows how a leading pharmaceutical company used AI to optimize engagement in their patient support program. The program saw 15 additional days on therapy compared to non-AI targeting, as well as 5 ...
Read

Overcoming barriers in physician partnerships

Pharmaceutical companies have aspired to make medication adherence programs more effective for years. A report from Credit Suisse shows that increased adherence could substantially increase revenue from 2020–2026 for leading pharma companies such as ...
Read

Establishing KPIs for your medication adherence program

Are you measuring what matters most for your brand? Many key performance indicators (KPIs) are used to measure the success of adherence programs, and they can vary across different pharmaceutical companies. According to Andrea Kasprzyk, Director of ...
Read

How pharma is advancing medication adherence

We live in exciting times for adherence, and the pharma industry is playing a critical role, according to Mark Degatano, a pharmaceutical industry analytics expert who is on the advisory board of AllazoHealth. Degatano’s expertise comes from 24 ...
Read

Why pharma companies should utilize real-world data

Eli Lilly and Co. and Abbott have made headlines recently for using real-world evidence to prove better adherence and outcomes for its diabetes products. More pharma companies are likely to utilize real-world data to support brands as access ...
Read

4 keys to a successful medication adherence program

With medication non-adherence costing the industry more than $600 billion a year, many pharmaceutical companies are creating medication adherence programs, often in conjunction with pharmacists and payers.
Read

AI-optimized pharma patient support program drives adherence

A leading pharmaceutical company engaged AllazoHealth on a multi-year project using artificial intelligence to optimize a patient support program for a major product.
Read